Axon Enterprise, Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +35

IFM Investors Pty Ltd Purchases 956 Shares of Axon Enterprise, Inc ...

AI-generated analysis

πŸ“ˆ IFM Investors Pty Ltd increased its AXON holdings by 6.3% in Q1, adding 956 shares to a total position valued at $6.81 million.

πŸ“Š Multiple hedge funds including Mayflower Financial Advisors (+12.5%) and Apollon Wealth Management (+13.1%) also boosted their stakes in the first quarter.

πŸ“‰ Barclays lowered its price target for AXON from $682 to $523, signaling a more cautious valuation outlook despite maintaining an overweight rating.

πŸ“ˆ Citizens Jmp raised its price target to $700 with a 'market outperform' rating, contrasting sharply with the bearish move by Barclays.

πŸ’° Insiders sold 48,989 shares worth approximately $24 million in the last ninety days, representing a net reduction in executive ownership.

πŸ“‰ Cameron Brooks, an executive at Axon Enterprise, sold 1,242 shares under a pre-arranged Rule 10b5-1 trading plan on June 4th.

πŸ“‰ Director Caitlin Elizabeth Kalinowski reduced her stake by 13.44% following the sale of 564 shares on June 1st.

πŸ“ˆ Institutional ownership remains high at 79.08%, indicating strong continued interest from professional money managers.

πŸ“Š The stock currently trades at a PE ratio of 239.78 and a PEG ratio of 12.12, reflecting high valuation multiples relative to earnings growth.

πŸ“‰ AXON stock opened at $597.04, trading above its 50-day moving average of $433.80 but well below its 12-month high of $885.91.

Bullish Signals
  • IFM Investors Pty Ltd increased its position by 6.3% in Q1, adding 956 shares to a total holding of 16,042 shares valued at $6.81 million.
  • Mayflower Financial Advisors LLC boosted its stake by 12.5%, acquiring an additional 67 shares for a total position worth $256,000.
  • Lansforsakringar Fondforvaltning AB publ increased its holdings by 5.5% to own 24,263 shares valued at $10.3 million.
  • Apollon Wealth Management LLC raised its position by 13.1%, purchasing 539 additional shares for a total value of $1.98 million.
  • Cornerstone Wealth Group LLC initiated a new position in AXON worth approximately $280,000 during the first quarter.
  • Union Bancaire Privee UBP SA increased its stake by 4.3% to own 1,457 shares valued at $619,000.
  • Citizens Jmp reissued a 'market outperform' rating and set a price target of $700.00 on AXON shares.
  • JPMorgan Chase & Co. lifted its price objective from $750.00 to $755.00 while maintaining an 'overweight' rating.
  • Piper Sandler restated an 'overweight' rating and set a price target of $674.00 for the company.
  • The consensus analyst average rating is 'Moderate Buy' with a collective target price of $712.75.
Risk Factors
  • Barcut cut its price objective on AXON shares from $682.00 to $523.00, indicating a significant downward revision in valuation expectations.
  • Insiders sold a total of 48,989 shares worth $24.09 million in the last ninety days, representing a net reduction in executive ownership.
  • Cameron Brooks, an executive at Axon Enterprise, sold 1,242 shares for $621,000, reducing his personal stake by 2.44%.
  • Director Caitlin Elizabeth Kalinowski sold 564 shares for $270,139, decreasing her ownership percentage by 13.44%.
  • The stock trades at a PE ratio of 239.78 and a PEG ratio of 12.12, suggesting the market is pricing in very high future growth expectations.
  • AXON stock opened at $597.04, which is significantly below its 12-month high of $885.91, indicating recent price weakness or consolidation.
Full Analysis
IFM Investors Pty Ltd increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 6.3% in the first quarter, purchasing an additional 956 shares to hold a total of 16,042 shares valued at $6.81 million. Several other institutional investors also adjusted their positions during the same period, with Mayflower Financial Advisors increasing holdings by 12.5%, Lansforsakringar Fondforvaltning AB boosting its stake by 5.5%, and Apollon Wealth Management rising its position by 13.1%. These filings indicate continued institutional interest in the company's stock. Analyst sentiment regarding Axon Enterprise remains mixed, with significant divergence in price targets and ratings among major financial institutions. Citizens Jmp reissued a 'market outperform' rating with a $700 price target, while Piper Sandler maintained an 'overweight' rating at $674. Conversely, Barclays cut its price objective from $682 to $523, though it retained an 'overweight' rating. The consensus average target price stands at $712.75 with a general 'Moderate Buy' rating, reflecting varied outlooks on the company's valuation and future performance. Insider trading activity shows net selling over the last ninety days, with executives Cameron Brooks and Caitlin Elizabeth Kalinowski reducing their personal holdings by 2.44% and 13.44% respectively. In total, insiders sold approximately 49,000 shares worth $24 million, though they still retain a 4.20% ownership stake in the firm. The stock recently opened at $597.04, trading above its 50-day moving average but below its 12-month high of $885.91.